December 31, 2025 18:02 ET | Source: Immutable Holdings Inc. VANCOUVER, British Columbia, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Immutable…
Independent audits and a Platinum CyberVadis rating demonstrate the rigor, resilience, and maturity of the OPUS platform—the industry's secure, audit-ready…
ARLINGTON, Va., Dec. 30, 2025 (GLOBE NEWSWIRE) -- OBOOK Holdings Inc. (NASDAQ: OWLS) (the “Company” or “OwlTing”), a blockchain technology…
The secondary analysis of the PACE trial highlights the value of counting Circulating Tumor Cells (CTCs) in the blood to…
December 12, 2025 16:30 ET | Source: Teva Pharmaceutical Industries Ltd TEL AVIV, Israel, Dec. 12, 2025 (GLOBE NEWSWIRE) --…
LUXEMBOURG and PARIS, Dec. 10, 2025 /PRNewswire/ -- FitLine is proud to announce a new partnership with Paris Basketball, the…
LEUVEN, BELGIUM – Euro NCAP’s independent assessment of the new CLA shows an outstanding safety performance with a five-star result…
December 10, 2025 04:00 ET | Source: Igyxos TOURS, France, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Igyxos Biotherapeutics, a biotechnology…
INNSBRUCK, Austria, Dec. 9, 2025 /PRNewswire/ -- As cyberattacks continue to challenge even the most resilient organisations, the need for…
Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a statistically significant reduction in countable motor seizure frequency (CMSF)…